116O Palbociclib (PAL) plus letrozole (L) as first-line (1L) therapy (tx) in postmenopausal Asian women with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC)
Titel:
116O Palbociclib (PAL) plus letrozole (L) as first-line (1L) therapy (tx) in postmenopausal Asian women with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC)
Auteur:
Im, S.-A. Mukai, H. Park, I.H. Masuda, N. Shimizu, C. Kim, S.B. Im, Y.-H. Ohtani, S. Bartlett, C.H. Lu, D.R. Mori, A. Gauthier, E. Finn, R.S. Toi, M.